ScholarIQanswers from OpenAlex
Lipoproteins and Cardiovascular Health
TopicLeading institutions, researchers & key papers
Lipoproteins and Cardiovascular Health is a topic indexed in ScholarIQ from OpenAlex.
What is known about Lipoproteins and Cardiovascular Health?
ScholarIQrecord summary
This cluster of papers focuses on the efficacy and safety of cholesterol-lowering treatments, particularly statins, in the prevention and management of cardiovascular diseases. It includes meta-analyses, clinical trials, guidelines, and genetic studies related to LDL cholesterol, atherosclerotic cardiovascular risk, hypercholesterolemia, and the role of C-reactive protein. The cluster also explores the impact of statins on various patient populations and their pleiotropic effects.
How many works does Lipoproteins and Cardiovascular Health have?
ScholarIQindexed works
Lipoproteins and Cardiovascular Health has 468 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Lipoproteins and Cardiovascular Health?
ScholarIQopenalex
The OpenAlex for Lipoproteins and Cardiovascular Health is on the source record.
What are the most-cited papers on Lipoproteins and Cardiovascular Health?
ScholarIQmost cited works
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
François Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimón, M. John Chapman, Guy G De Backer, Victoria Delgado, Brian A. Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, ESC Scientific Document Group, Christian Mueller, Heinz Drexel, Victor Aboyans, Alberto Corsini, Wolfram Doehner, Michel Farnier, Bruna Gigante, Meral Kayıkçıoğlu, Goran Krstačić, Ekaterini Lambrinou, Basil S. Lewis, Josep Masip, Philippe Moulin, Steffen E. Petersen, Anna Sonia Petronio, Massimo Piepoli, Xavier Pintó, Lorenz Räber, Kausik K. Ray, Željko Reiner, Walter F. Riesen, Marco Roffi, Jean-Paul Schmid, Е. V. Shlyakhto, Iain A Simpson, Erik S.G. Stroes, Isabella Sudano, Alexandros D. Tselepis, Margus Viigimaa, Cécile Vindis, Alexander Vonbank, Michal Vrablik, Mislav Vrsalović, José Luis Zamorano, Jean-Philippe Collet, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G De Backer, Victoria Delgado, Brian A. Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick E. Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S Lewis, Bela Merkely, Christian Mueller, Steffen E. Petersen, Anna Sonia Petronio, Dimitrios J Richter, Marco Roffi, Е. V. Shlyakhto
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Anders Olsson, John J.V. McMurray, G Thorgeirsson, Christian Spaulding, Jim Slattery, Kalevi Pyörälà, Ole Færgeman, R. Scott Wright, Katherine M. Berg, Lars Wilhelmsen, T.R. Pedersen, T. A. Miettinen, HD White, John Kjekshus, Michael Gnant
General Cardiovascular Risk Profile for Use in Primary Care
Ralph B. D’Agostino, Ramachandran S. Vasan, Michael Pencina, Philip A. Wolf, Mark R. Cobain, Joseph M. Massaro, William B. Kannel
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, Jean L. Rouleau, John D. Rutherford, Thomas Cole, Lisa Brown, J. Wayne Warnica, J. Malcolm O. Arnold, Chuan‐Chuan Wun, Barry R. Davis, Eugene Braunwald
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
James Shepherd, Stuart M. Cobbe, Ian Ford, Christopher Isles, A R Lorimer, Peter W. Macfarlane, James H. McKillop, Christopher J. Packard
Where is Lipoproteins and Cardiovascular Health research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Lipoproteins and Cardiovascular Health is open access?
ScholarIQopen access share
80%OPEN ACCESS